23andMe’s second act sits squarely in drug research and development

Next Story The next Apple Watch will have LTE cell service 23andMe is best known for its $199 at-home spit-tube DNA test, but the consumer genetics company has been making strides in the last few years to get into drug development and research. The company first began making moves early in 2015, forging a partnership with …

Continue reading “23andMe’s second act sits squarely in drug research and development”